Human genetic susceptibility to tuberculosis

Annals of the Academy of Medicine Singapore

Volumn 29, Issue 3, 2000, Pages 298-304

  Lim, T K ^a  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Genetic susceptibility; Immunogenetics; Natural resistance associated macrophage protein 1; Tuberculosis

Indexed keywords

CARRIER PROTEIN; CATION TRANSPORT PROTEIN; CYTOKINE; HLA ANTIGEN; MEMBRANE PROTEIN; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1; NATURAL RESISTANCE-ASSOCIATED MACROPHAGE PROTEIN 1;

ANIMAL; CELLULAR IMMUNITY; DISEASE MODEL; GENETIC PREDISPOSITION; GENETICS; HUMAN; IMMUNOLOGY; MACROPHAGE; PHYSIOLOGY; REVIEW; TUBERCULOSIS;

ANIMALS; CARRIER PROTEINS; CATION TRANSPORT PROTEINS; CYTOKINES; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; HLA ANTIGENS; HUMANS; IMMUNITY, CELLULAR; MACROPHAGES; MEMBRANE PROTEINS; TUBERCULOSIS;

EID: 0034182873     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Dye C, Scheele S, Dolin M P, Pathania V, Raviglione M C, for the WHO Global Surveillance and Monitoring Project, World Health Organization. Global burden of tuberculosis estimated incidence, prevalence, and mortality by country. JAMA 1999; 282:677-86.
2. Lim T K. Emerging pathogens for pneumonia in Singapore. Ann Acad Med Singapore 1997; 26:651-8.
3. Stead W W, Lofgren J P, Senner J W, Reddick W T. Racial differences in susceptibility to infection with M. tuberculosis. N Engl J Med 1990; 322:422-7.
4. Comstock G W. Tuberculosis in twins: a re-analysis of the Prophit survey. Am Rev Respir Dis 1978; 117:621-4.
5. Schluger N W, Rom W N. The host immune response to tuberculosis. Am J Respir Crit Care Med 1998; 157:679-91.
6. Fenton M J. Macrophages and tuberculosis. Curr Opin Hematol 1998; 5:72-8.
7. Stenger S, Modlin R L. T cell mediated immunity to Mycobacterium tuberculosis. Curr Opin Microbiol 1999; 2:89-93.
8. Beyers A D, van Rie A, Adams J, Fenhalls G, Gie R, Beyers N. Signals that regulate the host response to Mycobacterium tuberculosis. Novartis Found Sym 1998; 217:145-57.
9. Fearon D T. Seeking wisdom in innate immunity. Nature 1997; 388:323-4.
10. Medzhitov R, Janeway C A Jr. Innate immunity: the virtues of a nonclonal system of recognition. Cell 1997; 91:295-8.
11. Skamene E, Schurr E, Gros P. Infection genomics: Nramp 1 as a major determinant of natural resistance to intracellular infections. Ann Rev Med 1998; 49:275-87.
12. Unanue E R. Studies in listeriosis show the strong symbiosis between the innate cellular system and the T-cell response. Immunol Rev 1997; 158:11-25.
13. Rook G A W, Hernandez-Pando R, Lightman S L. Hormones, peripherally activated prohormones and regulation of Th1/Th2 balance. Immunol Today 1994; 15:301-3.
14. Henderson R A, Watkins S C, Flynn J L. Activation of human dendritic cells following infection with Mycobacterium tuberculosis. J Immunol 1997; 159:635-43.
15. Fulton S A, Cross J V, Toossi Z T, Boom W H. Regulation of interleukin-12 by interleukin-10, transforming growth factor-beta, tumor necrosis factor-alpha, and interferon-gamma in human monocytes infected with Mycobacterium tuberculosis H37Ra. J Infect Dis 1998; 178:1105-14.
16. Zhang M, Gong J, Presky D H, Xue W, Barnes P F. Expression of the IL-12 receptor beta 1 and beta 2 subunits inhuman tuberculosis. J Immunol 1999; 162:2441-7.
17. Casarini M, Ameglio F, Alemanno L, Zangrilli P, Mattia P, Paone G, et al. Cytokine levels correlate with a radiologic score in active pulmonary tuberculosis. Am J Respir Crit Care Med 1999; 159:143-8.
18. Condos R, Liu Y, Rom W, Schluger N. Local immune responses correlate with presentation and out come in tuberculosis. Am Respir Crit Care Med 1997; 157:729-35.
19. Hirsch C S, Ellner J J, Blinkhorn R, Toosi Z. In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against M. tuberculosis by natural inhibitiors of transforming growth factor beta. Proc Nat Acad Sci USA 1997; 94:3926-31.
20. Haas F, Haas S S. The origins of M. tuberculosis and the notion of its contagiousness. In: Rom W N, Garay S M, editors. Tuberculosis. New York: Little Brown & Co, 1996:3-19.
21. O'Brien S J, Ghetto legacy. Curr Biol 1991; 1:209-11.
22. Stead W W. Genetics and resistance to tuberculosis. Ann Intern Med 1992; 116:937-41.
23. Stead W W, Bates J H. Geographic and evolutionary epidemiology of tuberculosis. In: Rom W N, Garay S M, editors. Tuberculosis. New York: Little Brown & Co, 1996:77-83.
24. Sousa A O, Salem J I, Lee F K, Vercosa M C, Cruaud P, Bloom B, et al An epidemic of tuberculosis with a high rate of tuberculin anergy among a population previously unexposed to tuberculosis, the Yanomamindians of the Brazilian Amazon. Proc Nat Acad Sci USA 1997; 94:13227-32.
25. Margulies D H. Interactions of TCRs with MHC-peptide complexes: a quantitative basis for mechanistic models. Curr Opin Immunol 1997; 9:390-5.
26. Ou D, Mitchell L A, Tingle A J. A new categorization of HLA DR alleles on a functional basis. Hum Immunol 1998; 59:665-76.
27. Kumararatne D S, Pithie A, Drysdale P, Gaston J S, Kiessling R, Iles P B, et al. Specific lysis of mycobacterial antigen-bearing macrophages by class II MHC-restricted polyclonal T cell lines in healthy donors or patients with tuberculosis. Clin Expl Immunol 1990; 80:314-23.
28. Vordermeier H M. T-cell recognition of mycobacterial antigens. Eur Respir J 1995; 20:657S-667S.
29. McPeek M, Salkowitz J, Laufman H, Pearl D, Zwilling B S. The expression of HLA-DR black and white donor monocytes: different requirements for protein synthesis. Clin Exp Immunol 1992; 87:163-6.
30. Crowle A J, Elkins N. Relative permissiveness of macrophages from black and white people for virulent tubercle bacilli. Infect Immunol 1990; 58:632-5.
31. Agrewala J N, Wilkinson R J. Influence of HLA-DR on the phenotype of CD4+ T lymphocytes specific for an epitope of the 16-kDa alpha-crystallin antugen of M. tuberculosis. Eur J Immunol 1999; 29:1753-61.
32. Sanjeevi C B, Narayanan P R, Prabakar R, Charles N, Thomas B E, Balasubramaniam R, et al. No association or linkage with HLA-DR or -DQ genes in south Indians with pulmonary tuberculosis. Tuber Lung Dis 1992; 73:280-4.
33. Hawkins B R, Higins D A, Chan S L, Lowrie D B, Mitchison D A, Girling D J. HLA typing in Hong Kong Chest service/British Medical Research Council study of factors associated with the breakdown to active tuberculosis of inactive pulmonary lesions. Am Rev Respir Dis 1989; 140:1616-21.
34. Rajalingam R, Mehra N K, Jain R C, Myneedu V P, Pande J N. Polymerase chain reaction-based sequence-specific oligonucleotide hybridization analysis of HLA class II antigens in pulmonary tuberculosis. J Infect Dis 1996; 173:669-76.
35. Goldfeld A E, Delgado J C, Thim S, Bozon M V, Uglialoro A M, Turbay D, et al. Association of an HLA-DQ allele with clinical tuberculosis. JAMA 1998; 279:226-8.
36. Teran-Escandon D, Teran-Ortiz L, Camarena-Olvera A, Gonzalez-Avila G, Vaca-Marin M A, Granados J, et al. Human leukocyte antigen-associated susceptibility to pulmonary tuberculosis: molecular analysis of class II alleles by DNA amplification and oligonucleotide hybridization in Mexican patients. Chest 1999; 115:428-33.
37. Blackwell J M. Genetics of host resistance and susceptibility to intramacrophage pathogens: a study of multicase families of tuberculosis, leprosy and leishmaniasis in north-eastern Brazil. Int J Parasitol 1998; 28:21-8.
38. Qureshi S T, Skamene E, Malo D. Comparative genomics and host resistance against infectious diseases. Emerg Infect Dis 1999; 5:36-47.
39. Vidai S, Tremblay M L, Govoni G, Gauthier S, Sebastiani G, Malo D, et al. The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nrampl gene. J Exp Med 1995; 182:655-66.
40. Gruenheid S, Canonne-Hergaux F, Gauthier S, Hackman D J, Grinstein S, Gros P. The iron transport NRAMP2 is an integral membrane glycoprotein that colocalizes with transferring in recycling endosomes. J Exp Med 1999; 189:831-41.
41. Zwilling B S, Khun D E, Wikoff L, Brown D, Lafuse W. Role of iron in Nramp1-mediated inhibition of mycobacterial growth. Infect Immun 1999; 67:1386-92.
42. Rojas M, Olivier M, Gros P, Barrera L F, Garcia L F. TNF-alpha and IL-10 modulate the induction of apoptosis by virulent M. tuberculosis in murine macrophages. J Immunol 1999; 162:6612-31.
43. Abel L, Sanchez F O, Oberti J, Thuc N V, Hoa L V, Lap V D, et al. Susceptibility to leprosy is linked to the human NRAMP1 gene. J Infect Dis 1998; 177:133-45.
44. Bellamy R, Ruwende C, Corrah T, McAdam K P, Whittle H C, Hill A V. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med 1998; 338:640-4.
45. Shaw M A, Collins A, Peacock C S, Miller E N, Black G P, Sibthorpe D, et al. Evidence that genetic susceptibility to M. tuberculosis in a Brazilian population is under oligogenic control: linkage studies of condidate genes NRAMP1 and TNFA. Tuber Lung Dis 1997; 78:35-45.
46. Searle S, Blackwell J M. Evidence for functional repeat polymorphism in the promoter of human Nramp1 gene that correlates with autoimmune versus infectious disease susceptibility. J Med Genet 1999; 36:295-9.
47. Altare F, Jouanguy E, Lamhamedi S, Doffinger R, Fischer A, Casanova J L. Mendelian susceptibility to mycobacterial infection in man. Curr Opin Immunol 1998; 10:413-7.
48. Jouanguy E, Döffinger R, Dupuis S, Pallier A, Altare F, Casanova J L. IL-12 and IFN-gamma in host defense against mycobacteria and salmonella in mice and men. Curr Opin Immunol 1999; 11:346-51.
49. de Jong R, Altare F, Haagen I A, Elferink D G, Boer T, van Breda Vriesman P J, et al. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 1998; 280:1435-8.
50. Bellamy R, Ruwende C, Corrah T, McAdam K, Thursz M, Whittle H C, et al. Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J Infect Dis 1999; 179:721-4.
51. Roy S. Frodsham A, Saha B, Hazra S K, Mascie-Taylor C G, Hill A V. Association of vitamin D receptor genotype with leprosy type. J Infect Dis 1999; 179:187-91.
52. Eisman J A. Vatamin D receptor gene variants: implications for therapy. Curr Opin Genet Dev 1996: 6:361-5.
53. Wilkinson R J, Patel P, Llewelyn M, Hirsch C S, Pasovol G, Snounou G. et al. Influence of polymorphism in the gene for the interleukin-1 receptor antagonist and IL-1ß on tuberculosis. J Exp Med 1999: 189:1863-73.
54. Bellamy R. Genetics and pulmonary medicine.3.Genetic susceptibility to tuberculosis in human populations. Thorax 1998; 53:588-93.
55. Bellamy R. Hill A V S. Genetic susceptibility to mycobacteria and other infectious pathogens in humans. Curr Opin Immunol 1998; 10:483-7.
56. Hill A V. The immunogenetics of human disease. Ann Rev Immunol 1998; 16:593-617.
57. Schuler G D. Electronic PCR: bridging the gap between genome mapping and genome sequencing. Trends Biotech 1998; 16:456-9.
58. Collins F S. 1999. Shattuck lecture-medical and societal consequences of the Human Genome Project. N Engl J Med 1998; 341:28-37.
59. National Cancer Institute Genetic Annotation Initiative. http://lpg.nci.nih.gov/GAI
60. Wang D G, Fan J B, Siao C J, Berno A, Young P, Sploski R, et al. Large-scale identification, mapping, and genotyping ofsingle-nucleotide polymorphisms in the human genome. Science 1998; 280:1077-82.
61. Gilles P N, Wu D J, Foster C B, Dillon P J, Chanock S J. Single nucleotide polymorphic discrimination by an electronicdot blot assay on semiconductor microchips. Nat Biotechnol 1999; 17:365-70.